Posted by AI on 2025-09-04 00:08:24 | Last Updated by AI on 2025-09-04 04:17:16
Share: Facebook | Twitter | Whatsapp | Linkedin Visits: 1
Amid growing allegations and counterclaims, pharmaceutical entrepreneur Deepak Bhandari, detained in a narcotics case, claims conspiracy by NCB officer Sukhdeep Singh, while the latter refutes the accusation and requests a re-inspection. Was it a retaliation for the journalist's story on the officer? Full story below.
## Deepak Bhandari's Allegations
Ballista Pharmaceuticals owner Deepak Bhandari, in a social media live denounces the charges, claiming his company is legally licensed to purchase and supply Tramadol. He denies any misuse and emphasizes that their supplies only go to hospitals and registered doctors.
He alleges that Sukhdeep Singh, Drugs Control Officer, is guilty of misconduct and conspiracy, targeting him and his family. He insists it is an attempt to silence him and defame associates. He refers to his prior investigative story against the officer, suggesting it is retaliation.
## Sukhdeep Singh's Rebuttal
In a statement, Sukhdeep Singh denies any wrongdoing or conspiracy. He outlines instructions from Kulwinder Singh, the Zonal Licensing Authority in Amritsar, to join the NCB inspection of two hospitals. He alleges that CBI investigations into a previous attack on him by Deepak Bhandari found no evidence of wrongdoing.
He concludes by saying that Bhandari is trying to intimidate an honest officer, adding that he welcomes a fresh audit by different officers.
## Where Do We Stand?
The case, registered under the NDPS Act, alleges that partners of Ballista Pharmaceuticals and associated doctors from two hospitals in Amritsar illegally sold narcotics. Currently, Amit Bhandari is in NCB custody.
Deepak Bhandari claims that the case and alleged misconduct are conspiracy theories and attempts to intimidate him. On the other hand, Sukhdeep Singh denies any wrongdoing and alleges that Bhandari is trying to intimidate an honest officer.
As of today, Singh has asked his department to consider a re-inspection by an independent team.
Stay tuned as we bring you more updates on this developing story.